|
Index of reports
> Cases resulting in disability (2)
> Cases with Gastrointestinal Motility Disorder (1)
Below is the selection of adverse event reports related to Actiq (Fentanyl Oral Transmucosal) that includes cases resulting in disability where reactions include gastrointestinal motility disorder.
Adverse event in 43 year old female receiving Actiq (Fentanyl Oral Transmucosal)
Reported by a consumer/non-health professional from United States on 2007-03-12
Patient: 43 year old female, weighing 54.4 kg (119.7 pounds)
Adverse reactions / side effects: Gastrointestinal Motility Disorder, Intra-Uterine Death, Drug Exposure Before Pregnancy, Constipation, Twin Pregnancy, Abdominal Discomfort, Drug Exposure During Pregnancy, Swelling, Hypertension, Cardiac Failure Congestive, Infarction
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Suspect drug(s):
Duragesic-50
Dosage: patch see instructions transdermal
Indication: Abdominal Pain Upper
Duragesic-50
Dosage: patch see instructions transdermal
Indication: Gastrointestinal Disorder
Actiq
Dosage: 600 - 800mcg all day
Indication: Abdominal Pain Upper
Actiq
Dosage: 600 - 800mcg all day
Indication: Gastrointestinal Disorder
Actiq
Dosage: 600 - 800mcg all day
Indication: OFF Label USE
|
